Sarah A. Buhrow

1.1k total citations
24 papers, 773 citations indexed

About

Sarah A. Buhrow is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Sarah A. Buhrow has authored 24 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Sarah A. Buhrow's work include Cancer Treatment and Pharmacology (6 papers), Estrogen and related hormone effects (6 papers) and Cancer therapeutics and mechanisms (5 papers). Sarah A. Buhrow is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Estrogen and related hormone effects (6 papers) and Cancer therapeutics and mechanisms (5 papers). Sarah A. Buhrow collaborates with scholars based in United States, Australia and Switzerland. Sarah A. Buhrow's co-authors include Matthew M. Ames, Joel M. Reid, Stephanie L. Safgren, Michael J. Yaszemski, Chitta Ranjan Patra, Julie S. Lau, Shanfeng Wang, Debabrata Mukhopadhyay, Resham Bhattacharya and Shamit K. Dutta and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Sarah A. Buhrow

23 papers receiving 757 citations

Peers

Sarah A. Buhrow

BIOMA

ONCOL

GENET

Soon‐Kyung Hwang South Korea

Hyo Min Ahn South Korea

Francesco Mainini Italy

Armando Cevenini Italy

Jianping Wang China

Christian Chapa González Mexico

Francisco C. Pérez‐Martínez Spain

Hans H. Riese Spain

Qiuling Xie China

Meng Zhong United States

Soon‐Kyung Hwang South Korea

Sarah A. Buhrow

638 ×1.8

109 ×0.6

BIOMA

82 ×0.5

ONCOL

129 ×0.9

160 ×1.2

GENET

Citations per year, relative to Sarah A. Buhrow Sarah A. Buhrow (= 1×) peers Soon‐Kyung Hwang

Countries citing papers authored by Sarah A. Buhrow

Since Specialization

Citations

This map shows the geographic impact of Sarah A. Buhrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Buhrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Buhrow more than expected).

Fields of papers citing papers by Sarah A. Buhrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Buhrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Buhrow. The network helps show where Sarah A. Buhrow may publish in the future.

Co-authorship network of co-authors of Sarah A. Buhrow

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Buhrow. A scholar is included among the top collaborators of Sarah A. Buhrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Buhrow. Sarah A. Buhrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhattacharya, Sayantani Sarkar, Thomas R. Caulfield, Stephanie L. Safgren, et al.. (2025). Abstract P4-12-23: Z-Endoxifen-PROTAC, a novel drug for chemo-sensitive and-resistant Triple Negative Breast Cancer. Clinical Cancer Research. 31(12_Supplement). P4–12.

Buhrow, Sarah A., et al.. (2023). Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancer. Journal of Chromatography B. 1221. 123654–123654. 3 indexed citations

Al‐Kali, Aref, Ibrahim Aldoss, Pamela J. Atherton, et al.. (2023). A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia. Cancer Medicine. 12(23). 21229–21239. 6 indexed citations

Buhrow, Sarah A., Stephanie L. Safgren, Lee Jia, et al.. (2022). Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism. Drug Metabolism and Disposition. 51(2). 183–192. 2 indexed citations

Weaver, Samantha, Cortney A. Turner, Sarah A. Buhrow, et al.. (2021). Chondrocytic and pharmacokinetic properties of Phlpp inhibitors. SHILAP Revista de lepidopterología. 3(3). 100190–100190. 5 indexed citations

Buhrow, Sarah A., et al.. (2020). Reductive amination of α-Ketoglutarate in metabolite extracts results in glutamate overestimation. Journal of Chromatography A. 1623. 461169–461169. 2 indexed citations

Costello, Brian A., Jun Yin, Renee M. McGovern, et al.. (2020). Abstract CT114: Pharmacokinetic analysis of navitoclax in combination with sorafenib in patients with relapsed or refractory solid organ tumors. Cancer Research. 80(16_Supplement). CT114–CT114. 1 indexed citations

Goetz, Matthew P., Vera J. Suman, Joel M. Reid, et al.. (2020). Abstract PD7-06: A randomized phase II trial of tamoxifen versus Z-endoxifen HCL in postmenopausal women with metastatic estrogen receptor positive, HER2 negative breast cancer. Cancer Research. 80(4_Supplement). PD7–6. 5 indexed citations

Nevala, Wendy K., Sarah A. Buhrow, Daniel J. Knauer, et al.. (2016). Antibody-Targeted Chemotherapy for the Treatment of Melanoma. Cancer Research. 76(13). 3954–3964. 22 indexed citations

10.

Safgren, Stephanie L., Vera J. Suman, Matthew Kosel, et al.. (2015). Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen. Pharmacogenetics and Genomics. 25(4). 157–163. 10 indexed citations

11.

Reid, Joel M., Matthew P. Goetz, Sarah A. Buhrow, et al.. (2014). Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studies. Cancer Chemotherapy and Pharmacology. 74(6). 1271–1278. 34 indexed citations

12.

Reid, Joel M., Sarah A. Buhrow, Judith A Gilbert, et al.. (2014). Mouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993). Cancer Chemotherapy and Pharmacology. 73(6). 1137–1146. 34 indexed citations

13.

Reid, Joel M., Sarah A. Buhrow, Mary J. Kuffel, et al.. (2010). Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats. Cancer Chemotherapy and Pharmacology. 68(3). 777–786. 10 indexed citations

14.

Goetz, Matthew P., Kathryn E. Reinicke, Joel M. Reid, et al.. (2009). Tamoxifen, HER2, and Endoxifen: The Role of CYP2D6 as a Predictor of Tamoxifen Resistance in ER+/HER2+ Breast Cancer.. Cancer Research. 69(24_Supplement). 2006–2006. 1 indexed citations

15.

Patra, Chitta Ranjan, Resham Bhattacharya, Enfeng Wang, et al.. (2008). Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent. Cancer Research. 68(6). 1970–1978. 296 indexed citations

16.

Le, Son B., M. Katie Hailer, Sarah A. Buhrow, et al.. (2007). Inhibition of Mitochondrial Respiration as a Source of Adaphostin-induced Reactive Oxygen Species and Cytotoxicity. Journal of Biological Chemistry. 282(12). 8860–8872. 58 indexed citations

17.

Myers, Rae, Suzanne Greiner, Guy E. Griesmann, et al.. (2007). Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide. Clinical Pharmacology & Therapeutics. 82(6). 700–710. 105 indexed citations

18.

Jia, Lee, Karen Schweikart, Joseph E. Tomaszewski, et al.. (2007). Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity due to saturating absorption. Food and Chemical Toxicology. 46(1). 203–211. 79 indexed citations

19.

Buhrow, Sarah A., et al.. (2006). LC–MS/MS assay and dog pharmacokinetics of the dimeric pyrrolobenzodiazepine SJG-136 (NSC 694501). Journal of Chromatography B. 840(1). 56–62. 11 indexed citations

20.

Kuffel, Mary J., Sarah A. Buhrow, Joel M. Reid, Lee Jia, & Matthew M. Ames. (2005). Kynurenine: a biomarker for in vitro and in vivo modulation of indoleamine 2,3-dioxygenase by 1-Methyl-[D]-tryptophan (NSC 721782). 65. 982–982. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact